Biomerica (BMRA) EPS (Basic) (2010 - 2026)

Biomerica (BMRA) posted EPS (Basic) of -$0.44 for Q1 2026, up 3.98% sequentially from -$0.45 in Q4 2025, and up 10.12% YoY from -$0.4 in Q1 2025.

Biomerica (BMRA) EPS (Basic) (2010 - 2026) Analysis & Trends

Biomerica has reported EPS (Basic) for 17 years, with the latest figure at -$0.44 in Q1 2026.

Quarterly EPS (Basic) rose 10.12% year-over-year to -$0.44 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was -$1.39 (up 28.67% YoY) and the FY2025 annual result came in at -$2.16, up 21.38% from the prior year.
EPS (Basic) advanced to -$0.44 in Q1 2026 per BMRA's latest filing, from -$0.45 in the prior quarter.
Over five years, EPS (Basic) peaked at $0.0 in Q3 2025 and troughed at -$1.31 in Q2 2023.
A 5-year average of -$0.68 and a median of -$0.63 in 2024 frame the typical range for EPS (Basic).
The sharpest annual moves came in 2023 and 2025: EPS (Basic) slumped 1406.32% in 2023, then jumped 100.12% in 2025.
Over 5 years, EPS (Basic) stood at -$0.97 in 2022, then climbed by 25.87% to -$0.72 in 2023, then soared by 38.06% to -$0.44 in 2024, then decreased by 2.25% to -$0.45 in 2025, then rose by 3.98% to -$0.44 in 2026.
According to Business Quant data, EPS (Basic) over the past three periods registered -$0.44, -$0.45, and $0.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Basic) (Qtr)
1	Abbott Laboratories	200.19 Bn	194.59 Bn	7.27 Bn	0.53
2	Stryker	129.95 Bn	126.47 Bn	4.50 Bn	3.33
3	Medtronic	120.06 Bn	110.84 Bn	6.41 Bn	0.98
4	Boston Scientific	74.14 Bn	73.60 Bn	3.85 Bn	0.62
5	Edwards Lifesciences	52.74 Bn	48.49 Bn	1.35 Bn	0.42
6	Dexcom	34.60 Bn	32.65 Bn	830.00 Mn	0.65
7	GE HealthCare Technologies	34.20 Bn	32.10 Bn	2.18 Bn	1.27
8	Koninklijke Philips	26.46 Bn	23.13 Bn	4.55 Bn	0.65
9	Steris	23.25 Bn	22.77 Bn	684.20 Mn	2.06
10	Biomerica	4.58 Mn	3.24 Mn	-44,000.00	-0.44

Download Data